Statsenko M.E.; Turkina S.V.

References:

Gavrilova NE, Meletskaya VA, Yarovaya EB, Boytsov SA. Carotid artery duplex scan in diagnosing coronary atherosclerosis and asssing its severity. Rossijskij kardiologicheskij zhurnal. 2014;(4):108-112. (In Russ.). doi: 10.15829/1560-4071-2014-4-108-112
Oganov RG. Vascular comorbidity: general approaches to prevention and treatment. Racionalnaya-farmakoterapiya v kardiologii. 2015;11(1):4-7. (In Russ.).
Rumyantsevа SA, Oganov RG, Silinа EV, Stupin VA, Bolevich SB, Svishcheva SP, Orlovа AС, Komarov AN, Orlov VA, Abroskina ОB, Eliseev EV, Sohova OA, Bogatyrevа MD. The modern concept of treating patients with vascular comorbidity Part 1. Correction of tissue energy shortage. Kardiovaskulyarnaya terapiya i profilaktika. 2012;(6):44-49. (In Russ.).
Vertkin AL, Skotnikov AS, Algian EA, Magomedov AA, Abdullaeva AU. Neurological problemsof comorbid patients. Arhiv vnutrennej mediciny. 2014;1(15): 7-14. (In Russ.).
Vertkin AL, Nosov AV, Hovasova NO, Skotnikov AS, Rodyukova IS. Patients with myocardial infarction, in the outpatient clinic at the therapist. Consilium Medicum. 2013;15(10):150-159. (In Russ.).
Diagnosis and treatment of hypertension. Russian recommendations (revision 4). 2010;34. (In Russ.).
Mancia G, Fagard R, Narkiewicz K, et al. ESH/ESC Guidelines for the management of arterial hypertension. Eur Heart J. 2013;34:2159-2219. doi: http://dx.doi.org/10.1093/eurheartj/eht1512159-2219
James PA, Oparil S, Carter BL, et al. Evidence-based guideline for the management of high blood pressure in adults. Report from the panel members appointed to the Eighth Joint National Committee (JNC8). JAMA. 2014;311(5):507-520. doi: 10.1001/jama.2013.284427
National Society for the Study of Atherosclerosis (PLA). Russian Society of Cardiology. Russian society of kardiosomatich rehabilitation and secondary prevention (RosOKR). Diagnostics and correction of disorders of lipid metabolism in the prevention and treatment of atherosclerosis. Russian recommendations. V review. 2012;50. (In Russ.).
Boytsov SA, Kukharchuk VV, Karpov UA, Sergienko IV, Drapkina OM, Semenov AE, Urazalina SJ. Subclinical atherosclerosis as a risk factor for cardiovascular complications. Kardiovaskulyarnaya terapiya i profilaktika. 2012;11(3):82-86. (In Russ.).
De Backer G, Graham I, Taskinen, et al. ESC/EAS Guidelines for the management of dyslipidemias. Eur Heart J. 2011;32:1769-1818. doi: 10.1093/eurheartj/ehr158
Montalescot G, Sechtem U, Achenbach S, et al. ESC Guidelines on management of stable coronary disease. Eur Heart J. 2013;34(38):2949-3003. doi: http://dx.doi.org/10.1093/eurheartj/eht296
Ronnett GV, Ramamurthy S, Kleman AM, Landree LE, Susan A. AMPK in the Brain: Its Roles in Energy Balance and Neuroprotection. J Neurochem. 2009 May;109(Suppl 1):17-23. doi: 10.1111/j.1471-4159.2009.05916.x
Hossain MI, Roulston CL, Stapleton DI. Molecular Basis of Impaired Glycogen Metabolism during Ischemic Stroke and Hypoxia. PLoS ONE. 2014;9(5):e97570. doi: 10.1371/journal.pone.0097570
Camara Amadou KS, Bienengraeber M, Stowe DF. Mitochondrial approaches to protect against cardiac ischemia and reperfusion injury Front. Physiol. 2011. http://dx.doi.org/10.3389/fphys.2011.00013
Voronina TA. Mexidol: spectrum of pharmacological effects. Zhurnal nevrologii i psihiatrii. 2012;12:86-90. (In Russ.).
Statsenko ME, Turkina SV, Kosivtsova MA. Features of mexicor as part of combination therapy in patients with coronary heart disease and type 2 diabetes. Klinicheskaya medicina. 2013;91(5):59-64. (In Russ.).
Suslina ZA, Smirnova IN, Tanashyan MM, Kistenev BA, Sharypova TN. Mexidol for chronic forms of cerebrovascular diseases. Lechenie nervnyh boleznej. 2002;3(8):28-33. (In Russ.).
Tanashyan MM, Lagoda OV, Antonova KV. Chronic cerebrovascular disease and metabolic syndrome, new approaches to the treatment. Zhurnal nevrologii i psihiatrii. 2012;11:21-26. (In Russ.).
Chukanova EI, Chukanova AS, Mamaev HI. The results of research on the effectiveness and safety of mexidol patients with chronic brain ischemia patients. Zhurnal nevrologii i psihiatrii.2015;2:71-74. (In Russ.). doi: 10.17116/jnevro20151152171-74
Shishkova VN. Neuroprotection in hypertensive patients: to minimize the adverse forecast. Terapevticheskij arhiv. 2014;8:113-118. (In Russ.).
Rumyantseva SA, Stupin VA, Oganov RG. The theory and practice of the treatment of patients with cardiovascular comorbidity. Klinicheskoe rukovodstvo. 2013;360. (In Russ.).
Nechaeva G.I., Korennova O.Yu., Bulakhova E.Yu., Kozyreva V.A., Kurochkina S.D. Ispol'zovanie preparata meksidol dlya optimizatsii lecheniya arterial'noi gipertenzii u lits molodogo vozrasta. Medicinskij vesti. 2008;6-7:433-434. (In Russ.).
Turkina S, Kosivtsova MA, Shilina NN, Lempert BA. Effect of 2-ethyl-6-metilgidroksipiridina succinate on the elastic properties of the arteries in patients with chronic heart failure and type 2 diabetes. Vestnik volgogradskogo gosudarstvennogo medicinskogo universiteta. 2014;4(52):84-87. (In Russ.).
Sidorenko GI, Komissarova SM, Zolotukhin SF, Petrovskaya ME. Application emoxypine in the treatment of patients with heart failure. Kardiologia. 2011;6:44-48. (In Russ.).
Statsenko ME, Evtereva ED, Turkina SV, Fabritskaya SV, Sporova OE. New features of mexicor in the treatment of chronic heart failure in patients with metabolic syndrome. Rossijskij kardiologicheskij zhurnal. 2010;6(86):28-33. (In Russ.).
Eremenko AA, Zyulyaeva TP, Egorov VM, Fomin MA. Drug organoprotection during CABG with cardiopulmonary bypassy. Consilium medicum. 2008;8:115-117. (In Russ.).
Eremenko AA, Zyulyaeva TK, Egorov YV. Influence of mexidol on the severity of the systemic inflammatory response in patients undergoing myocardial revascularization operations under extracorporeal circulation. Kardiologiya i serdechno-sosudistaya hirurgiya. 2008;1:67-72. (In Russ.).
Nechayev GI, Kurochkin SD, Trotsenko AD, Bulakhov EY. Mexidol in the treatment of stable angina. Kardiologia. 2013;1:33-39. (In Russ.).
Mukhin VP. Cytoprotection in cardiology: achievements and prospects. Part 2. Arhiv vnutrennej mediciny. 2014;2(16):33-40. (In Russ.).